These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35904299)

  • 1. [Epilepsy in Angelman syndrome].
    Bobylova MY; Mukhin KY; Kuzmich GV; Glukhova LY; Pylayeva OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):100-105. PubMed ID: 35904299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy in Angelman syndrome: A scoping review.
    Samanta D
    Brain Dev; 2021 Jan; 43(1):32-44. PubMed ID: 32893075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose ethosuximide for epilepsy in Angelman syndrome: implication of GABA(A) receptor subunit.
    Sugiura C; Ogura K; Ueno M; Toyoshima M; Oka A
    Neurology; 2001 Oct; 57(8):1518-9. PubMed ID: 11673606
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome.
    Galván-Manso M; Campistol J; Conill J; Sanmartí FX
    Epileptic Disord; 2005 Mar; 7(1):19-25. PubMed ID: 15741136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches.
    Fitzgerald PJ
    Epilepsy Res; 2024 Feb; 200():107286. PubMed ID: 38217951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13.
    Valente KD; Koiffmann CP; Fridman C; Varella M; Kok F; Andrade JQ; Grossmann RM; Marques-Dias MJ
    Arch Neurol; 2006 Jan; 63(1):122-8. PubMed ID: 16401744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations.
    Mercadé Cerdá JM; López Gonzalez FJ; Serrano Castro P; Castro Vilanova MD; Campos Blanco DM; Querol Pascual MR;
    Neurologia (Engl Ed); 2020 Mar; 35(2):115-125. PubMed ID: 29530436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital.
    Shaaya EA; Grocott OR; Laing O; Thibert RL
    Epilepsy Behav; 2016 Jul; 60():138-141. PubMed ID: 27206232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary.
    Leo A; Caro C; Nesci V; Palma E; Tallarico M; Iannone M; Constanti A; Sarro G; Russo E; Citraro R
    Pharmacol Rep; 2019 Oct; 71(5):833-838. PubMed ID: 31386986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy with myoclonic-atonic seizures (Doose syndrome): Clarification of diagnosis and treatment options through a large retrospective multicenter cohort.
    Nickels K; Kossoff EH; Eschbach K; Joshi C
    Epilepsia; 2021 Jan; 62(1):120-127. PubMed ID: 33190223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental view of epilepsy in Angelman syndrome: a questionnaire study.
    Ruggieri M; McShane MA
    Arch Dis Child; 1998 Nov; 79(5):423-6. PubMed ID: 10193256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic focal epilepsies of infancy and childhood].
    Ermolenko NA; Ermakov AIu; Buchneva IA; Voronkova KV; Zakharova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):17-24. PubMed ID: 22611673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy in patients with Angelman syndrome.
    Fiumara A; Pittalà A; Cocuzza M; Sorge G
    Ital J Pediatr; 2010 Apr; 36():31. PubMed ID: 20398390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapeutic management of seizures in patients with Angleman Syndrome.
    Samanta D
    Expert Opin Pharmacother; 2022 Sep; 23(13):1511-1522. PubMed ID: 35862628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
    Thibert RL; Conant KD; Braun EK; Bruno P; Said RR; Nespeca MP; Thiele EA
    Epilepsia; 2009 Nov; 50(11):2369-76. PubMed ID: 19453717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.